[Lonazolac-Ca = Calcium [3-(p-chlorophenyl)-1-phenylpyrazole-4[ -acetate 1 Pharmacological properties of a new antiinflammatory/antirheumatic drug (author's transl)].
D000085:Acetates / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002415:Cats; D005260:Female; D006168:Guinea Pigs; D008297:Male; D051379:Mice; D010276:Parasympatholytics; D011720:Pyrazoles / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013045:Species Specificity
D000085:Acetates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010276:Parasympatholytics; D011720:Pyrazoles; C017472:lonazolac
Pharmakologische Eigenschaften von Lonazolac-Ca, einer neuen antiphlogistisch und antirheumatisch wirksamen Substanz.